Michael Morrissey - 24 May 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Director
Signature
Michael M. Morrissey, /s/ Chu Lee, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
24 May 2022
Net transactions value
$0
Form type
4
Filing time
25 May 2022, 16:18:24 UTC
Previous filing
08 Mar 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 24 May 2022 Class A Common Stock 40,000 $16.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest monthly over a three-year period, subject to the Reporting Person's continuous service on each vesting date.